Literature DB >> 14532194

Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3'-minor groove binder-DNA probes.

H Rogier van Doorn1, Eric C J Claas, Kate E Templeton, Adri G M van der Zanden, Arianne te Koppele Vije, Menno D de Jong, Jacob Dankert, Ed J Kuijper.   

Abstract

Tuberculosis remains one of the leading infectious causes of death worldwide. The emergence of drug-resistant strains of Mycobacterium tuberculosis is a serious public health threat. Resistance to isoniazid (INH) is the most prevalent form of resistance in M. tuberculosis and is mainly caused by mutations in the catalase peroxidase gene (katG). Among high-level INH-resistant isolates (MIC > or = 2), 89% are associated with a mutation at codon 315 of katG. There is a need to develop rapid diagnostic tests to permit appropriate antibiotic treatment and to improve clinical management. Therefore, a single-tube real-time PCR, using a novel kind of probe (3'-minor groove binder-DNA probe), was developed to detect either the wild-type or the mutant codon directly in Ziehl-Neelsen-positive sputum samples. The detection limit of the assay for purified DNA was 5 fg per well (one mycobacterial genome), and with spiked sputum samples, it was 20 copies per well, corresponding to 10(3) mycobacteria per ml of sputum. Sputum samples from 20 patients living in Kazakhstan or Moldova and infected with monodrug- or multidrug-resistant M. tuberculosis and 20 sputum samples from patients infected with INH-susceptible M. tuberculosis were tested. The sensitivities and specificities of the probes were 70 and 94% for the wild-type probe and 82 and 100% for the mutant probe. Binding to either probe was nonambiguous. This real-time PCR allows the rapid identification of a mutant katG allele and can easily be implemented in a clinical microbiology laboratory.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532194      PMCID: PMC254323          DOI: 10.1128/JCM.41.10.4630-4635.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis.

Authors:  A S Piatek; S Tyagi; A C Pol; A Telenti; L P Miller; F R Kramer; D Alland
Journal:  Nat Biotechnol       Date:  1998-04       Impact factor: 54.908

3.  New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis.

Authors:  Darío García de Viedma; Maria del Sol Díaz Infantes; Fátima Lasala; Fernando Chaves; Luis Alcalá; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains.

Authors:  M Ristow; M Möhlig; M Rifai; H Schatz; K Feldmann; A Pfeiffer
Journal:  Lancet       Date:  1995-08-19       Impact factor: 79.321

5.  A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia.

Authors:  H J Marttila; H Soini; E Eerola; E Vyshnevskaya; B I Vyshnevskiy; T F Otten; A V Vasilyef; M K Viljanen
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

6.  Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands.

Authors:  D van Soolingen; P E de Haas; H R van Doorn; E Kuijper; H Rinder; M W Borgdorff
Journal:  J Infect Dis       Date:  2000-10-26       Impact factor: 5.226

7.  Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance.

Authors:  D A Rouse; J A DeVito; Z Li; H Byer; S L Morris
Journal:  Mol Microbiol       Date:  1996-11       Impact factor: 3.501

8.  Rendering of mycobacteria safe for molecular diagnostic studies and development of a lysis method for strand displacement amplification and PCR.

Authors:  P Zwadyk; J A Down; N Myers; M S Dey
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

9.  Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study.

Authors:  B Heym; N Honoré; C Truffot-Pernot; A Banerjee; C Schurra; W R Jacobs; J D van Embden; J H Grosset; S T Cole
Journal:  Lancet       Date:  1994-07-30       Impact factor: 79.321

10.  Catalase-peroxidase gene sequences in isoniazid-sensitive and -resistant strains of Mycobacterium tuberculosis from New York City.

Authors:  M Y Stoeckle; L Guan; N Riegler; I Weitzman; B Kreiswirth; J Kornblum; F Laraque; L W Riley
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

View more
  17 in total

1.  Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy.

Authors:  Paolo Miotto; Federica Piana; Valeria Penati; Filippo Canducci; Giovanni Battista Migliori; Daniela Maria Cirillo
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

Review 2.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDR.

Authors:  Hyeeun Bang; Sangjung Park; Joohwan Hwang; Hyunwoo Jin; Eunjin Cho; Dae Yoon Kim; Taeksun Song; Isdore Chola Shamputa; Laura E Via; Clifton E Barry; Sang-Nae Cho; Hyeyoung Lee
Journal:  J Med Microbiol       Date:  2011-05-19       Impact factor: 2.472

4.  Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.

Authors:  Doris Hillemann; Michael Weizenegger; Tanja Kubica; Elvira Richter; Stefan Niemann
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Fast test for assessing the susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by real-time PCR.

Authors:  Maria Gisele Gonçalves; Lucila Okuyama Fukasawa; Rosangela Siqueira Oliveira; Maristela Marques Salgado; Lee H Harrison; Kathleen A Shutt; Claudio Tavares Sacchi
Journal:  Mem Inst Oswaldo Cruz       Date:  2012-11       Impact factor: 2.743

6.  Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR.

Authors:  Mercedes Marín; Darío García de Viedma; María Jesús Ruíz-Serrano; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance.

Authors:  Florence Brossier; Nicolas Veziris; Chantal Truffot-Pernot; Vincent Jarlier; Wladimir Sougakoff
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

Review 8.  Newer diagnostic modalities for tuberculosis.

Authors:  Rakesh Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2004-03       Impact factor: 1.967

9.  Effects of treatment on free radicals in patients with pulmonary tuberculosis in South Western Nigeria.

Authors:  Wasiu Olalekan Adebimpe; Ayodeji Oluwaseun Faremi; Sulaiman Adebayo Nassar
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

10.  Convergent evolutionary analysis identifies significant mutations in drug resistance targets of Mycobacterium tuberculosis.

Authors:  Manzour Hernando Hazbón; Alifiya S Motiwala; Magali Cavatore; Michael Brimacombe; Thomas S Whittam; David Alland
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.